| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BMS-536924 | CTRPv2 | pan-cancer | AAC | 0.07 | 0.07 |
| mRNA | ISOX:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.067 | 0.07 |
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | -0.064 | 0.07 |
| mRNA | BRD-K26531177 | CTRPv2 | pan-cancer | AAC | -0.071 | 0.07 |
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | -0.053 | 0.08 |
| mRNA | BRD-K41334119 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.08 |
| mRNA | linifanib | CTRPv2 | pan-cancer | AAC | -0.067 | 0.08 |
| mRNA | BRD-K63431240 | CTRPv2 | pan-cancer | AAC | -0.067 | 0.08 |
| mRNA | BRD-K45681478 | CTRPv2 | pan-cancer | AAC | 0.069 | 0.08 |
| mRNA | ABT-263 | CTRPv2 | pan-cancer | AAC | 0.067 | 0.08 |